fluorouracil has been researched along with selenocystine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, W; Chen, J; Chen, T; Fan, C; Wang, Y; Wong, YS; Zhang, Y; Zheng, W | 1 |
1 other study(ies) available for fluorouracil and selenocystine
| Article | Year |
|---|---|
Selenocystine potentiates cancer cell apoptosis induced by 5-fluorouracil by triggering reactive oxygen species-mediated DNA damage and inactivation of the ERK pathway.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Cystine; DNA Damage; Drug Synergism; Fluorouracil; Humans; In Situ Nick-End Labeling; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Organoselenium Compounds; Reactive Oxygen Species | 2013 |